MICHELLE SCHWARZ: Open Payments
NPI 1760055164 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,356 in 109 payments from 47 companies in 2025. Trend: 2023 $2,407 · 2024 $2,154 · 2025 $2,356
Food & beverage: $2,356
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $212 |
| Genentech USA, Inc. | 7 | $169 |
| Novartis Pharmaceuticals Corporation | 7 | $151 |
| Daiichi Sankyo Inc. | 7 | $141 |
| Merck Sharp & Dohme LLC | 5 | $105 |
| E.R. Squibb & Sons, L.L.C. | 4 | $98 |
| ABBVIE INC. | 4 | $95 |
| Lilly USA, LLC | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| TerSera Therapeutics LLC | 2 | $68 |
Products named: ENHERTU, DARZALEX, KEYTRUDA, Tecentriq, VERZENIO, KISQALI, IMBRUVICA, Lenvima.
Industry payments across MO — which companies pay providers there.
